UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059709
Receipt number R000068240
Scientific Title Outcomes of robot-assisted versus conventional laparoscopic right hemicolectomy for colon cancer: a propensity-matched analysis of the National Clinical Database in Japan
Date of disclosure of the study information 2025/11/10
Last modified on 2025/11/10 01:19:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Outcomes of robot-assisted versus conventional laparoscopic right hemicolectomy for colon cancer: a propensity-matched analysis of the National Clinical Database in Japan

Acronym

NCD RoRHC study

Scientific Title

Outcomes of robot-assisted versus conventional laparoscopic right hemicolectomy for colon cancer: a propensity-matched analysis of the National Clinical Database in Japan

Scientific Title:Acronym

NCD RoRHC study

Region

Japan


Condition

Condition

colon cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to elucidate the safety and efficacy of robot-assisted right hemicolectomy for colonic malignancies using big data from the National Clinical Database (NCD). Furthermore, we will analyze the learning curve of robot-assisted right hemicolectomy and evaluate perioperative outcomes of robot-assisted surgery for colonic malignancies based on cases registered in the NCD Robot Registry.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of all postoperative complications of Clavien Dindo grade II or higher within 30 days after surgery

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients who underwent conventional laparoscopic or robot-assisted right hemicolectomy between January 1, 2023 and December 31, 2024, and were registered in the National Clinical Database (NCD).
2. Cases in which the admission diagnosis was recorded as C189 Malignant neoplasm of colon.
3. Cases that received preoperative chemotherapy are included.
4. No age restriction was applied.

Key exclusion criteria

None

Target sample size

14000


Research contact person

Name of lead principal investigator

1st name Yusuke
Middle name
Last name Kinugasa

Organization

Institute of Science Tokyo

Division name

Department of Gastrointestinal Surgery

Zip code

113-8519

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan

TEL

03-5803-5254

Email

kinugasa.srg1@tmd.ac.jp


Public contact

Name of contact person

1st name Sakiko
Middle name
Last name Oba

Organization

Institute of Science Tokyo Department of Gastrointestinal Surgery

Division name

Department of Gastrointestinal Surgery

Zip code

113-0001

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan

TEL

08012836251

Homepage URL


Email

asano.sakiko@tmd.ac.jp


Sponsor or person

Institute

The Japanese Society of Gastroenterological Surgery

Institute

Department

Personal name



Funding Source

Organization

Institute of Science Tokyo

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institute of Science Tokyo Institutional Review Board for Medical Research

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8519, Japan

Tel

03-5803-5254

Email

rinri.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2025 Year 12 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2025 Year 11 Month 10 Day

Last modified on

2025 Year 11 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068240